Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.09.09
关于签署《召募资金三方羁系协议》的通告
2015.09.08
关于公司股票暂时停牌的希望通告
2015.09.08
关于以集中竞价方法回购股份的报告书
2015.09.08
北京市中伦(深圳)状师事务所关于公司回购部分社会公众股份的执法意见书
2015.09.02
关于为全资子公司申请银行贷款提供反担保的通告
2015.09.02
关于召开2015年第二次暂时股东大会的通知通告
2015.09.02
第三届监事会第十一次聚会决议通告
2015.09.02
第三届董事会第十六次聚会决议通告
2015.09.01
关于公司股票暂时停牌的希望通告
2015.08.29
2015年半年度财务报告
第一页
上一页
93
94
95
96
97
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】